-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GXM/zl6Iel/pyT/09iovuzwxc7652V/pgSpvsHE8gC7Dc/rnuRo8VUr4u8qbnSDw Act2kd8Du5FXfW5e4a7Hkg== 0000950109-97-004059.txt : 19970515 0000950109-97-004059.hdr.sgml : 19970515 ACCESSION NUMBER: 0000950109-97-004059 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970514 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: RENAL TREATMENT CENTERS INC /DE/ CENTRAL INDEX KEY: 0000899169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 232518331 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-10839 FILM NUMBER: 97604513 BUSINESS ADDRESS: STREET 1: 1180 WEST SWEDESFORD RD STREET 2: BLDG 2, STE 300 CITY: BERWYN STATE: PA ZIP: 19312 BUSINESS PHONE: 2156444796 MAIL ADDRESS: STREET 1: 1180 WEST SWEDESFORD ROAD BLDG 2 STREET 2: SUITE 300 CITY: BERWYN STATE: PA ZIP: 19312 424B3 1 PROSPECTUS SUPPLEMENT SUPPLEMENT NO. 8 DATED MAY 9, 1997 TO PROSPECTUS DATED SEPTEMBER 3, 1996 RELATING TO $125,000,000 PRINCIPAL AMOUNT 5 5/8% CONVERTIBLE SUBORDINATED NOTES DUE 2006 AND 3,654,971 SHARES OF RENAL TREATMENT CENTERS, INC. COMMON STOCK, $.01 PAR VALUE All capitalized terms used but not defined herein shall have the meanings prescribed in the Prospectus dated September 3, 1996, as supplemented by Supplement No. 1 dated December 2, 1996, Supplement No. 2 dated December 9, 1996, Supplement No. 3 dated January 6, 1997, Supplement No. 4 dated January 13, 1997, Supplement No. 5 dated February 18, 1997, Supplement No. 6 dated March 17, 1997 and Supplement No. 7 dated April 30, 1997, forming a part of Form S-3 Registration Statement No. 333-10839. The purpose of this supplement is to provide additional information regarding the Selling Securityholders. The Selling Securityholders in the table below are identified by this supplement. The Notes beneficially owned by these Selling Securityholders were previously listed in the Prospectus under the names of the nominee or Depository Trust Company participant holding the Notes for the benefit of the Selling Securityholders or the persons from whom the Selling Securityholders purchased the Notes. The table has been prepared based upon information furnished to the Company by or on behalf of the Selling Securityholders identified therein.
PRINCIPAL AMOUNT OF NOTES NUMBER OF PERCENTAGE BENEFICIALLY OWNED PERCENTAGE CONVERSION SHARES OF COMMON THAT MAY OF NOTES THAT MAY STOCK NAME BE SOLD OUTSTANDING BE SOLD (1) OUTSTANDING (2) - ------------------------- ------------------------------------ ------------ ------------------ ------------------------------ Austin Firefighters $ 150,000 * 4,385 * Baptist Hospital $ 136,000 * 3,976 * Boston Museum of Fine Arts $ 53,000 * 1,549 * Dufor Inv LP $ 18,000 * 526 * Dunham & Associates $ 29,000 * 847 * Dunham & Associates Fund I $ 49,000 * 1,432 * Dunham & Associates Fund II $ 20,000 * 584 * Engineers Joint Pension $ 194,000 * 5,672 * Fund Laterman Strategies, 90's $ 180,000 * 5,263 * LLC Laterman & Co. $ 120,000 * 3,508 * Nicholas- Applegate Income $1,202,000 * 35,146 * & Growth Fund Occidental College $ 120,000 * 3,508 * Offshore Strategies, Ltd. $ 300,000 * 8,771 * Christine Rawlinson $ 24,000 * 701 * San Diego City Retirement $ 398,000 * 11,637 * San Diego County $1,458,000 1.2% 42,631 * Wake Forest University $ 312,000 * 9,122 * Ernest Wuliger Trust $ 60,000 * 1,754 * - --------------------
* Less than 1%. (1) Assumes conversion of the full amount of Notes held by such holder at the current conversion rate of $34.20 in principal amount of Notes per share of Common Stock. Under the terms of the Indenture, fractional shares will not be issued upon conversion of the Notes; cash will be paid in lieu of fractional shares, if any. (2) Computed in accordance with Rule 13d-3(d)(i) promulgated under the Exchange Act based upon the 24,617,217 shares of Common Stock outstanding as of March 14, 1997, treating as outstanding the number of Conversion Shares shown as being issuable upon the assumed conversion by the named holder of the full amount of such holder's Notes but not assuming the conversion of the Notes of any other holders. Other than their ownership of the Company's securities, none of the foregoing Selling Securityholders has had any material relationship with the Company within the past three years.
-----END PRIVACY-ENHANCED MESSAGE-----